Enquiry

Department of Respiratory Medicine

Academics Extension and Research
List of Publications
  1. Barthwal M S , Singh S. Early detection of Chronic Obstructive Pulmonary Disease in Asymptomatic Smokers using Spirometry. J Assoc Physicians India. 2014; 62(3): 238- 42.
  2. Khandagale S, Agarawal R, Barthwal M S, Salvi D. A randomized Control Trial of Treatment of Bronchial Asthma with Inhaled Salbutamol Combined with Pursed Lip Breathing. Indian J of Physiotherapy & occupational Therapy- An International Journal. 2014;8(1):215-20.
  3. Hingorani M, Dharmadhikari V, Gupta A, Sahasrabudhe T. Respiratory Health of Auto Rickshaw Drivers. Research Journal of Pharmaceutical, Biological and Chemical Sciences. May – June 2014; 5(3):1799-1805.
  4. Sahasrabudhe T, Salvi S. Should treatment for MDR Tubecrculosisbe individualized? JAPI.July 2014;62:564-5.
  5. ChirstopherD J Shankar A, Datey A, Zwerling A,,Pai M. Safety of the two-step tuberculin skin test in Indian health care workers. International Journal of Mycobacteriology, 2014: 3(4)
  6. Udwadia Z F, Amale R A, Mullerpattan J B, Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India. International journal of tuberculosis and lung disease. 2014;18(11).
  7. Kapse V , Bagrecha M, Totewad D, Gosavi M. A Study Of Association Of Body Mass Index With Severity Of Bronchial Asthma In 132 Patients. Journal of evoluation of medicine and dentists science.2014 ; 3(2);7058-7066.
  1. Kumar S, Sahasrabudhe T, Pathak A, Gupta A, Wilson V. Awareness of use of Monteux test for the diagnosis of tuberculosis in medical practitioners of PCMC area of Pune.IJSAR.2015;2(11):20-29.
  2. Sahasrabudhe T. MDR-TB: What has made the battle tough? RespiMirror. May- June 2015;V(II):1-2.
  3. Mhase A, Sahasrabudhe T, Meshram S. Study of adherence of patients of OAD (obstructive airway diseases) to inhalational devices. RJPBCS. May-June 2015; 6(3): 511-5.
  4. Singh P, Dharmadhikari V, Sahasrabudhe T. Knowledge of bronchial asthma in parents/caregivers of adolescent asthma patients. RJPBCS. May-June 2015; 6(3): 516-20.
  5. Mehta K, Sahasrabudhe T. Spirometry assessment of persons doing regular aerobic exercises. RJPBCS. May-June 2015; 6(3): 521-3.
  6. KaradeS,Pandey S, Gianchandani S, Kurale S. N., Gaikwad N. S ., Rewari B.B. Near full length genomic characterization of a novel CRF01_AE/Cr recombinant from western India. AIDS Resarch And Human Retrovirus: Dec 2015.
  7. Ghate M, Kadam D, Gaikwad N. HIV drug resistance, early warning indicators and quality care in India. WHO Journal of Public Health SERO article July Dec 15.
  8. Yannawar A, Duggal D.Uncommon cause of Asthma Like Presentation.RJPBCS. May- June 2015; 6(3):661-4
  9. Datey A S, Datey A. Endobronchial Tuberculosis: An unusual presentation of a common disease. International journal of medicine and public health. 2015: 5(1)
  10. Ghate M, Narkhe H, Rahane G, Nirmalkar A, Gaikwad, Kadam D,. Cognitive Function among HIV Infected Children in Pune. The Indian journal of paedratic. 2015:82(6)
  11. Gabhale S D , Taparia P, Yadav D, Agnihotri S P. Usefulness of pleural fluid CRP level in differnetial ,Diganosis of excudative pleural effusion – a pilot study. International journal of clinical biochemistry & research.2015;2(2)
  1. Rahul T, Barthwal M S, Bhattacharya D, Katoch CDS. Pyopneumothorax of Rare Case. Lung India. 2016; 33: 79-81.
  2. Barthwal MS, Bagrecha A, Dhoka A.Bronchoalveolar lavage and high-resolution computed tomography in interstitial lung disease. Lung India. Sep-Oct 2016; 33(5):580- 81.
  3. Barthwal MS, Tyagi R, Kishore K. Fibrinolytics in loculated abscess cavities- A report of two cases. Lung India. Jul-Aug 2016; 33(4):417-19.
  4. Barthwal MS et al. A Five –year study of InterapleuralFibrinolytic therapy in loculatedpleurak collections. The Indian Journal of Chest Diseases & Allied Sciences.2016; 58: 17-20.
  5. Chamberlain D, Kodgule R, Thorat Y, Das V, Miglani V, Ganelin D, Dalal A, Sahasrabudhe T, Lanjewar A, Fletcher R.Smart phone-based auscultation platform. European Respiratory Journal 2016 48: OA2000; DOI: 10.1183/13993003.congress- 2016.OA2000.
  6. Gaikwad N,Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India. Medicine:95(37):2016.
  7. Dole SK, Gauri P Godbole, Himanshu S PophaleTo study efficacy of medical thoracoscopy in indiagonosed pleural effusion: Journal of the association of physicians of India : 64(37-40):2016.
  8. Kattakkayam A. J, Mehta K, Deshpande P. Saber sheath Trachea as a marker of severe airflow obstruction. IJSAR. 2016; 3(3): 32-4.
  9. Takhar R P, Bunkar M , Jain S , Gabhale S. Tarcheal Diverticulum: an unusual cause of chronic cough and recurrent respiratory infection. TuberkToraks; 2016;64(1)
  10. Atre S . Tuberculosis burden in India's private sector. The Lancet Infectious Diseases.2016;16(12)
  1. Barthwal M S, Meshram S. A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation. Lung India. 2017; 34(1): 111-12.
  2. Barthwal M S, Kalrani A L, Sahasrabudhe T,Atre S, Meshram S. Prevalence of dysglycemia& clinical presentation of pulmonary tuberculosis in westenindia: International journal tuberculosis lung disease.21(12):2017
  3. Gaikwad N, GeneXpert HIV-1 quant assay, a new tool for scale up of viral load monitoring in the success of ART programme in India: BMC infectous Diseases:2017:17(506).
  4. Dole SK, Waghmare VN, AM Shaikh Clinical profile & treatment outcome of drug resistant tuberculosis patient od western Maharashtra, India: Journal of the association of physicians of India: 65(18-21):2017
  5. Sahasrabudhe T, Ajani F.Lung Agenesis: A Case Report Indian journal of Applied Research.7(3):2017
  6. Sahasrabudhe T, Attipatla S. Pulmonary Alveolar Microlithiasis: Clinical & radiopathological review, International Journal of advanced research:5(2);2017
  7. Atre S. Modelling approaches for tuberculosis: are they realistic?. The Lancet Global Health.2017; 5(3).
  8. Javed A, Dharmadhikari V, Sharma E. A Case Report On Pulmonary Hypertension And Pulmonary Fibrosis. International Journal Of Scientific Research.2017;6(9)
  9. Joseph T , Dharmadhikari V ,Kulkarni A. Prevalence of Tuberculosis among Community Acquired Pneumonia Diagnosed Patients. Journal of Pulmonary & Respiratory Medicine.2017;7(6)
  10. Chopra M, Bhattacharyya D, Barthwal M S,Madan G D S,Chakrabarthy B, Pandey I M, Chopra M. Cough of more than two weeks – Time to think beyond. Indian journal of tuberculosis;2017, 204.
  11. Atre S. Tuberculosis burden in India's private sector. The Lancet Infectious Diseases. 2016 Dec 1;16(12):1328-9.
  12. GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet. 2017 Sep 16; 390 (10100):1423-1459. doi: 10.1016/S0140-6736(17)32336-X. Epub 2017 Sep 12.
  13. GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017 Sep 16; 390(10100):1084- 1150. doi: 10.1016/S0140-6736(17)31833-0.
  14. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017 Sep 16; 390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.
  1. Sahasrabudhe T , Yadav K. International journal of current research, Assessment Of Respiratory Tract Inflammatory Marker With Overnight Use Of Mosquito Repellent In Copd Patient And Normal Individual, V-10 I-2 February 2018.65090-65096
  2. Mehta K, Barauh G, Harshad Azeem E.K., Jain S, Indian journal of immunology and respiratory medicine , Management of cold Abscess : A noval Approach.3(1) 24-25 jan.- March2018
  3. Barthwal M.S., Sahasrabudhe T, Meshram S, Atre S, international journal tuberculosis lung diseases,Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India.22(7),feb2018.
  4. Barthwal M S, Sahasrabudhe T, Atre S,The effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatmentinetics and pharmacodynamics of tuberculosis treatment; Antimicrobial Agents and Chemotherapy 2018;62(11)
  5. Atre;Failure in TB control: why should the rapid diagnostic test bear the blame?;The international journal of tuberculosis and lung disease;2018; 22(9)
  6. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1789-1858.
  7. GBD 2017 Causes of Death Collabo
  8. rators (2018). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1736-1788.
  9. GBD 2017 SDG Collaborators (2018). Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 2091-2138.
  10. Kyu, H. H., Maddison, E. R., Henry, N. J., Ledesma, J. R., Wiens, K. E., Reiner Jr, R., ... & Carter, A. (2018). Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. The Lancet Infectious Diseases, 18(12), 1329-1349.
  1. Bagrecha M , Gabhale S. A study of arterial blood gases with chronic obstructive pulmonary disease in a tertiary care hospital. International journal of scientific research.2019;8(8)
  2. Atre S . The burden of diabetic in India. The Lancet Global health. 2019;7(2)